Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial

Ethan Basch, Charles S. Cleeland, Christopher J. Logothetis et al.|The Lancet Oncology|2013

Cited by 153